HALO logo
halo search icon
Compugen Ltd.
Compugen Ltd.
CGEN · NAS

Compugen Ltd.

US$2.70

Price Arrow-0.025 (-0.916%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleEngulfing BullishHALO AllHammer BearishHammer Bearish (Realtime)Recent Earnings downgrade+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Compugen Ltd. Overview

CGEN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Weak

About CGEN

icon

Telephone

972.3.765.8585

icon

Address

Building D, 26 Harokmim Street, Azrieli Center, Holon, Tel Aviv 58858

Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

CGEN Price Chart

Key Stats

Market Cap

US$258.13M

PE

4.10

EV/EBITDA

-0.1

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.29 - 3.23

Trade Value (12mth)

US$181,447.00

1 week

-0.73%

1 month

-3.87%

YTD

76.13%

1 year

96.4%

All time high

19.90

Key Fundamentals

EPS 3 yr Growth

-197.20%

EBITDA Margin

43.70%

Operating Cashflow

$32m

Free Cash Flow Return

38.90%

ROIC

43.50%

Interest Coverage

0.00

Quick Ratio

6.60

Other Data

Shares Outstanding (Fully Diluted)

95m

HALO Sector

Healthcare

Next Company Report Date

09-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CGEN Announcements

Latest Announcements

DateAnnouncements
19 May 26
18 May 26
02 March 26
02 March 26
02 March 26

CGEN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.21-0.160.38locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.21-0.160.38locklocklock
Growth
%locklocklocklock4525.7337.9locklocklock
PE
XlocklocklocklockN/AN/A4.1locklocklock
EV/EBITDA
XlocklocklocklockN/AN/A-0.1locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Compugen Ltd. (CGEN:NAS)?
Halo FAQ
The current share price of Compugen Ltd. (CGEN:NAS) is USD$2.70.
What is the 52-week high share price for Compugen Ltd. (CGEN:NAS)?
Halo FAQ
The 52-week high share price for Compugen Ltd. (CGEN:NAS) is USD$3.23.
What is the 52-week low share price for Compugen Ltd. (CGEN:NAS)?
Halo FAQ
The 52-week low share price for Compugen Ltd. (CGEN:NAS) is USD$1.29.
What is the dividend yield for Compugen Ltd. (CGEN:NAS)?
Halo FAQ
Compugen Ltd. (CGEN:NAS) does not pay a dividend.
What was Compugen Ltd. (CGEN:NAS) last dividend payment?
Halo FAQ
Compugen Ltd. (CGEN:NAS) does not pay a dividend.
What is the franking level for Compugen Ltd. (CGEN:NAS)?
Halo FAQ
Compugen Ltd. (CGEN:NAS) has a franking level of 0.00%.
In which sector is Compugen Ltd. (CGEN:NAS) classified?
Halo FAQ
Compugen Ltd. (CGEN:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Compugen Ltd. (CGEN:NAS)?
Halo FAQ
The current P/E ratio for Compugen Ltd. (CGEN:NAS) is 4.10.

See beyond the curve.

One solution for research, investing and portfolio management.